Sino Biopharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	105,300	110,478	58,258	63,845	84,459	102,408
Market Cap Growth	74.42%	89.64%	-8.75%	-24.41%	-17.53%	-27.33%
Enterprise Value	110,795	115,449	64,462	66,382	90,167	114,126
Last Close Price	5.89	6.18	3.16	3.35	4.32	5.03
PE Ratio	40.78	42.37	15.64	24.85	29.37	5.71
Forward PE	20.53	21.62	17.48	17.77	20.63	12.33
PS Ratio	2.97	3.12	1.90	2.21	2.87	3.11
PB Ratio	2.25	2.36	1.28	1.52	1.97	2.21
P/TBV Ratio	4.01	4.20	1.78	1.96	2.59	2.84
P/FCF Ratio	-	-	9.68	11.60	14.88	22.84
P/OCF Ratio	-	-	8.28	9.55	11.93	15.55
PEG Ratio	1.03	0.84	1.24	1.34	-	0.62
EV/Sales Ratio	3.13	3.26	2.10	2.30	3.07	3.46
EV/EBITDA Ratio	13.77	14.05	8.79	9.45	12.75	17.05
EV/EBIT Ratio	16.22	16.49	10.44	11.08	14.81	20.07
EV/FCF Ratio	-	-	10.71	12.06	15.88	25.46
Debt / Equity Ratio	0.38	0.38	0.23	0.33	0.37	0.33
Debt / EBITDA Ratio	2.18	2.18	1.39	1.97	2.22	2.21
Debt / FCF Ratio	-	-	1.72	2.54	2.81	3.36
Net Debt / Equity Ratio	-0.15	-0.15	-0.12	-0.04	-0.07	-0.09
Net Debt / EBITDA Ratio	-0.88	-0.88	-0.74	-0.22	-0.45	-0.65
Net Debt / FCF Ratio	-	-	-0.90	-0.28	-0.56	-0.97
Asset Turnover	0.45	0.45	0.45	0.41	0.42	0.50
Inventory Turnover	2.47	2.47	2.44	2.31	2.10	2.79
Quick Ratio	1.16	1.16	1.11	0.90	1.15	1.38
Current Ratio	1.37	1.37	1.26	1.05	1.29	1.53
Return on Equity (ROE)	12.53%	12.53%	11.82%	12.12%	11.94%	55.25%
Return on Assets (ROA)	5.56%	5.56%	5.62%	5.33%	5.40%	5.37%
Return on Invested Capital (ROIC)	13.52%	13.14%	14.13%	12.90%	13.46%	15.24%
Return on Capital Employed (ROCE)	12.40%	12.40%	12.70%	13.30%	12.30%	10.30%
Earnings Yield	2.48%	2.36%	6.39%	4.02%	3.40%	17.51%
FCF Yield	-	-	10.33%	8.62%	6.72%	4.38%
Dividend Yield	1.70%	1.62%	2.20%	1.46%	2.78%	1.59%
Payout Ratio	-	-	52.76%	27.13%	49.84%	6.42%
Buyback Yield / Dilution	1.30%	1.30%	1.26%	2.57%	1.38%	-2.57%
Total Shareholder Return	3.00%	2.92%	3.46%	4.03%	4.16%	-0.98%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.